Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 29, 2020

SELL
$8.57 - $12.69 $180,912 - $267,885
-21,110 Closed
0 $0
Q2 2020

Jul 28, 2020

SELL
$8.12 - $13.12 $28,013 - $45,264
-3,450 Reduced 14.05%
21,110 $260,000
Q1 2020

May 04, 2020

BUY
$6.69 - $13.45 $93,660 - $188,300
14,000 Added 132.58%
24,560 $221,000
Q4 2019

Jan 29, 2020

BUY
$6.53 - $10.72 $68,956 - $113,203
10,560 New
10,560 $103,000
Q4 2018

Feb 08, 2019

SELL
$14.59 - $23.84 $53,837 - $87,969
-3,690 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$21.06 - $25.65 $77,711 - $94,648
3,690 New
3,690 $79,000
Q2 2018

Aug 13, 2018

SELL
$16.77 - $24.71 $67,734 - $99,803
-4,039 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$16.68 - $22.07 $18,531 - $24,519
-1,111 Reduced 21.57%
4,039 $69,000
Q4 2017

Feb 09, 2018

BUY
$11.23 - $19.1 $57,834 - $98,365
5,150
5,150 $98,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.